About this trial
This cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovascular health, atrial fibrillation management, self-management adherence, and heart failure prevention among older rural patients with atrial fibrillation in China.
Eligibility criteria
Qualifiers
None
Disqualifiers
A definite history of heart failure, or confirmed cardiac dysfunction or heart failure based on echocardiography and/or NT-proBNP screening. Diagnostic criteria include typical heart failure symptoms or signs with reduced left ventricular ejection fraction (HFrEF, LVEF <40%), mildly reduced left ventricular ejection fraction (HFmrEF, LVEF 40-49%), or preserved left ventricular ejection fraction with elevated NT-proBNP and structural heart disease evidence (HFpEF, LVEF ≥50%, with at least one of the following: LAVI >40 mL/m², E/e' ≥15, or TRV >2.8 m/s).
Expected survival of less than 12 months.
Severe renal insufficiency, defined as creatinine clearance <30 mL/min, or currently receiving dialysis treatment.
Cardiac dysfunction caused by reversible secondary causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
Trial design
Treatments tested in this trial
- Village-Doctor Led Integrated Care
- Usual Care
Treatment groups
Sponsors and collaborators
Jiangsu Taizhou People's Hospital
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborator